Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Asthma drug may boost daily steps in severe cases

NCT ID NCT05404763

First seen Apr 25, 2026 · Last updated May 24, 2026 · Updated 5 times

Summary

This study looks at whether mepolizumab, a drug already used to reduce asthma attacks, can also help people with severe asthma become more physically active. Researchers will track daily steps and exercise tolerance in 62 adults over six months. The goal is to see if the treatment improves how much people move in their daily lives.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Lille University Hospital

    Lille, France

Conditions

Explore the condition pages connected to this study.